Fujirebio
Davos Alzheimer's Collaborative Creates Initiative to Improve Alzheimer's Diagnosis
Under the program, blood biomarkers and confirmatory diagnostic testing will be used to increase diagnosis of Alzheimer’s disease and related dementias.
Two studies, led by researchers at Oxford and University College London, aim to explore whether blood-based markers can speed up diagnoses and improve outcomes.
Top Five Articles on 360Dx Last Week: FDA 510(k) Clearances; QuidelOrtho Update; More
Last week, readers were most interested in a story about FDA clearances granted in February.
Beckman Coulter, Fujirebio Expand Partnership to Develop Neurodegenerative Disease Assays
Last year, the companies announced they would partner to develop blood-based immunoassays for Alzheimer's disease.
Fujirebio Europe Picks up Distribution Rights to Self-screen's RUO Anal Cancer Assay
The assay is designed to detect promoter hypermethylation of the genes ASCL1 and ZNF582, a hallmark of HPV-induced cancer, for risk stratification of anal lesions.